Early Treatment Attrition After Recurrence Following Neoadjuvant Chemo-Immunotherapy in Triple-Negative Breast Cancer
Triple-negative breast cancer is sending researchers back to a difficult question: what happens when an aggressive tumor returns after receiving ...
